From January 1, 2024 to March 30, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,400,000 shares, representing 2.49% for $164.24 million under the buyback announced on November 8, 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.72 USD | +2.33% | +2.06% | -13.86% |
11/07 | Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating | MT |
10/07 | Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.86% | 377.88Cr | |
+55.35% | 82TCr | |
+32.36% | 60TCr | |
-0.10% | 38TCr | |
+15.47% | 32TCr | |
+13.10% | 31TCr | |
+16.15% | 25TCr | |
+14.34% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- PRGO Stock
- News Perrigo Company plc
- Tranche Update on Perrigo Company plc's Equity Buyback Plan announced on November 8, 2018.